The product associated with this complaint was not returned to the manufacturer for analysis.A review of the manufacturing records for this device was completed and no issues were identified that could have led to the adverse event reported.There is no indication that a malfunction of the srm device occurred.At this time, it is unknown if the reported event is related to procedural issues, resistance to the dapt regimen, or a silk road medical device failure, hence, the event will be reported out of abundance of caution.Complaints will continue to be reviewed and monitored for trends.All reasonably available information has been provided by the company at the time of submission of this report.The fields that are blank are not an omission and indicate that the information is either not applicable or currently unavailable.If additional information is received, a supplemental report will be filed.
|
It was reported that two hours after the completion of a transcarotid artery revascularization (tcar) procedure, the patient experienced facial droop and contralateral weakness.It was reported that the patient was on dual anti-platelet treatment (dapt), but it is unknown if the patient was resistant to the dapt regimen.At this time it is unclear if the reported event is due to patient's resistance to medication, procedural complications, or a silk road medical device failure; hence will be reported out of an abundance of caution.
|